[ET Net News Agency, 10 June 2019] Ausnutria Dairy Corporation Ltd (01717) said its
subsidiary Ausnutria Dairy Investments Limited (the subscriber) has conditionally agreed
to subscribe for convertible bonds in the principal amount of US$30 million.
Assuming the conversion rights attaching to the convertible bonds are exercised in full
by the subscriber, the subscriber will hold 30 million conversion shares, representing
26.1% of the issued share capital of Genlac Biotech International Corporation as enlarged
by the issuance of the conversion shares.
Glac Biotech Co. Ltd will be indirectly owned by the subscriber. It is one of the major
players in Taiwan and the PRC in the research and development, manufacture and sale of
probiotics- and fermentation-related application products. (RC)